by Commetric | Oct 14, 2021 | Blog
For a long time, the media debate around Alzheimer’s has been dominated by news of failed clinical trials – giants such as Merck, Eli Lilly and Pfizer, as well as lesser-known companies like Axovant and Prana Biotech, have all announced...
by Commetric | Oct 8, 2021 | Blog
The COVID-19 pandemic has exacerbated preexisting mental health challenges, giving a stronger impetus to the debate around depression and anxiety in both healthcare and mass media. Our media analysis found that the conversation in health industry outlets was mainly...
by Commetric | Sep 29, 2021 | Newsroom
We are very proud to have been shortlisted for ten AMEC Awards in eight categories. The annual AMEC Awards is run by the International Association for Measurement and Evaluation of Communication and celebrates excellence in communications measurement. Our pharma team...
by Commetric | Aug 13, 2021 | Blog
While pharma companies experienced reputational boosts thanks to the rapid vaccine development, they are now facing increasing pressure to introduce new Covid treatments, as more and more experts assert that vaccination alone won’t be enough to handle the...
by Commetric | Jul 23, 2021 | Blog
The pandemic put mRNA in the media spotlight, with many stories reporting that the novel technology could be used beyond Covid. Our analysis found that mRNA’s success seen with Pfizer and Moderna has started to change the conversation around diseases such as...
